tetraiodothyroacetic acid has been researched along with Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WJ; Chen, YR; Chin, YT; Chu, HR; Davis, PJ; De Vito, P; Gionfra, F; Hsiung, CN; Huang, CH; Huang, HM; Huang, TY; Incerpi, S; Lee, SY; Li, ZL; Lin, CY; Lin, HY; Pan, YS; Pedersen, JZ; Unson, S; Wang, K; Whang-Peng, J | 1 |
1 other study(ies) available for tetraiodothyroacetic acid and Carcinoma
| Article | Year |
|---|---|
Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gingival Neoplasms; Humans; Terpenes; Thyroxine | 2020 |